Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 2, 1998, Pages 678-686

  Dunbar, Stuart A ^a   Pulai, Istvan J ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIZOCILPINE; MORPHINE SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG TOLERANCE; DRUG WITHDRAWAL; HYPERALGESIA; INTRATHECAL DRUG ADMINISTRATION; MALE; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT;

EID: 0031909502     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Adams ML, Kalicki JM, Meyer ER and Cicero TJ (1993) Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester. Life Sci 52:245-249.
2. Backonja MM, Miletic G and Miletic V (1995) The effect of continuous morphine analgesia on chronic thermal hyperalgesia due to sciatic constriction injury in rats. Neurosci Lett 196:61-64.
3. Basbaum AI (1995) Insights into the development of opioid tolerance. Pain 61:349-352.
4. Ben Eliyahu S, Marek P, Vaccarino AL, Mogil JS, Sternberg WF and Liebeskind JC (1992) The NMDA receptor antagonist MK-8OI prevents long-lasting non-associative morphine tolerance in the rat. Brain Res 575:304-308.
5. Bharagava HN (1978) The effects of naltrexone on the development of physical dependence on morphine. Eur J Pharmacol 50:193-202.
6. Bhargava HN (1995) Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthase. Gen Pharmacol 26:1049-1053.
7. Cappendijk SL, De Vries R and Dzoljic MR (1993) Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Neurosci Lett 162:97-100.
8. Carstens E, Tulloch I, Zieglgansberger W and Zimmerman M (1979) Presynaptic excitability changes induced by morphine in single cutaneous afferent C and A fibres. Pfleugers Arch 379:143-147.
9. Coderre TJ and Melzack R (1992) The role of NMDA receptor-operated calcium channels in persistent nociception after formalin-induced tissue injury. J Neurosci 12:3671-3675.
10. Collier HOJ (1966) Tolerance, physical dependence and receptors. Adv Drug Res 3:171-188.
11. Collingdridge GL and Bliss TVP (1987) NMDA receptors; their role in long-term potentiation. Trends Neurosci 10:288-294.
12. Cox BM, Ginsberg M and Willis J (1975) The offset of morphine tolerance in mice. Br J Pharmacol 53:383-391.
13. Crain SM, Crain B, Peterson ER and Simon EJ (1979) Development of tolerance to opiates and opioid peptides in organotypic cultures of mouse spinal cord. Life Sci 25:1797-1802.
14. Crain SM and Shen KF (1995) Chronic morphine-treated sensory ganglion neurons remain supersensitive to the excitatory effects of naloxone for months after return to normal culture medium: an in vitro model of protracted opioid dependence. Brain Res 694:103-110.
15. Dickenson AH (1994) Neurophysiology of opioid poorly responsive pain. Cancer Surv 21:5-16.
16. Dunbar SA and Yaksh TL (1996a) Concurrent spinal infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat. Anesthesiology 84:1177-1188.
17. Dunbar SA and Yaksh TLPD (1996b) Spinal infusion of N-methyl-D-aspartate antagonist MK801 induces hypersensitivity to the spinal alpha-2 agonist ST91 in the rat. J Pharmacol Exp Ther 281:1219-1225.
18. Ekblom. M, Hammarlund-Udenaes M and Paalzow L (1993) Modeling of tolerance development and rebound effect during different intravenous administrations of morphine to rats. J Pharmacol Exp The. 266:244-252.
19. Elliott K, Minami N, Kolesnikov YA, Pasternak GW and Inturrisi CE (1994) The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain 56:69-75.
20. Farber NB, Foster J, Duhan NL and Olney JW (1995) Alpha 2 adrenergic agonists prevent MK-801 neurotoxicity. Neuropsychopharmacology 12:347-349.
21. Feng J and Kendig JJ (1995) N-methyl-D-aspartate receptors are implicated in hyperresponsiveness following naloxone reversal of alfentanil in isolated rat spinal cord. Neurosci Lett 189:128-130.
22. Ferreira SH and Lorenzetti BB (1994) Glutamate spinal retrograde sensitization of primary sensory neurons associated with nociception. Neuropharmacology 33:1479-1485.
23. Gold LH, Stinus L, Inturrisi CE and Koob GF (1994) Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. Eur J Pharmacol 253:45-51.
24. Gutstein HB, Trujillo KA and Akil H (1993) MK801 inhibits the development of morphine tolerance in the rat at spinal sites. Soc Neurosci 18:332-334.
25. Hargreaves EL and Cain DP (1995) MK801-induced hyperactivity: duration of effects in rats. Pharmacol Biochem Behav 51:13-19.
26. Ibuki T, Dunbar SA and Yaksh TL (1997) Effect of transient naloxone antagonism on tolerance development in rats receiving continuous spinal infusion. Pain 70:125-132.
27. Jessell TM and Iversen LL (1977) Opiate analgesics inhibit substance P release from rat trigeminal nucleus. Nature 268:549-551.
28. Jhamandas KH, Marsala M, Ibuki T and Yaksh TL (1996) Spinal amino acid release and precipitated withdrawal in rats chronically infused with spinal morphine. J Neurosci 16:2758-2766.
29. Johnson SM and Duggan AW (1981) Tolerance and dependence of dorsal horn neurones of the cat: the role of the opiate receptors of the substantia gelatinosa. Neuropharmacology 20:1033-1038.
30. Mao J, Price DD and Mayer DJ (1994) Thermal hyperalgesia in association with the development of morphine tolerance in rats: role of excitatory amino acid receptors and protein kinase C. J Neurosci 14:2301-2312.
31. Mao J, Price DD and Mayer DJ (1995) Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 61:353-364.
32. Marek P, Ben Eliyahu S, Gold M and Liebeskind JC (1991a) Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res 547:77-81.
33. Marek P, Ben Eliyahu S, Vaccarino AL and Liebeskind JC (1991b) Delayed application of MK-801 attenuates development of morphine tolerance in rats. Brain Res 558:163-165.
34. Mayer DJ, Mao J and Price DD (1993) The development of morphine tolerance is associated with increases in membrane bound protein kinase C: Prevention by GM1 ganglioside. Soc Neurosci 19:1796.
35. Nakki R, Koistinaho J, Sharp FR and Sagar SM (1995) Cerebellar toxicity of phencyclidine. J Neurosci 15:2097-2108.
36. Neil A, Kayser V, Chen YL and Guilbaud G (1990) Repeated low doses of morphine do not induce tolerance but increase the opioid antinociceptive effect in rats with a peripheral neuropathy. Brain Res 522:140-143.
37. Neugebauer V, Lucke T and Schaible HG (1993) N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists block the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint. J Neurophyaiol 70:1365-1377.
38. Okano K, Kuraishi Y and Satoh M (1995) Effects of intrathecally injected glutamate and substance P antagonists on repeated cold stress-induced hyperalgesia in rats Biol Pharm Bull 18:42-44.
39. Orahovats PD, Winter CA and Lehman EG (1953) The effect of N-allylnormorphine upon the development of tolerance to morphine in the albino rat. J Pharmacol Exp Ther 109:413-416.
40. Raigorodsky G and Urea G (1987) Intrathecal N-methyl-D-aspartate (NMDA) activates both nociceptive and antinociceptive systems. Brain Res 422:158-162.
41. Rasmussen K (1995) The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal. Neuropsychopharmacology 13:295-300.
42. Sastry BR (1979) Presynaptic effects of morphine and methionine-enkephalin in feline spinal cord. Neuropharmacology 18:367-375.
43. Satoh M, Zieglgansberger W and Herz A (1976) Supersensitivity of cortical sensory neurons of the rat to acetylcholine and 1-glutamate following chronic morphine treatment. Naunyn-Schmiedeberg's Arch Pharmacol 293:101-103.
44. Sher GD and Mitchell D (1990) Intrathecal N-methyl-D-aspartate induces hyperexcitability in rat dorsal horn convergent neurones. Neurosci Lett 119:199-202.
45. Sluka KA and Westlund KN (1993) Spinal cord amino acid release and content in an arthritis model: the effects of pretreatment with non-NMDA, NMDA, and NK1 receptor antagonists. Brain Res 627:89-103.
46. Sorkin LS (1993) NMDA evokes an LName sensitive spinal release of glutamate and citrulline. Neuroreport 4:479-482.
47. Srivastava RK, Gombar KK, Kaur AH and Khosla P (1995) Attenuation of morphine-induced antinociception by L-glutamic acid at the spinal site in rats. Can J Anaesth 42:541-546.
48. Stevens CW, Monasky MS and Yaksh TL (1988) Spinal infusion of opiate and alpha-2 agonists in the rats: Tolerance and cross tolerance studies. J Pharmacol Exp Ther 244:63-70.
49. Stevens CW and Yaksh TL (1989a) Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion. J Pharmacol Exp Ther 250:1-8.
50. Stevens CW and Yaksh TL (1989b) Time course characteristics of tolerance development to continuously infused antinociceptive agents in rat spinal cord. J Pharmacol Exp Ther 251:216-223.
51. Thorat SN, Barjavel MJ, Matwyshyn GA and Bhargava HN (1994) Comparative effects of NG-monomethyl-L-arginine and MK-801 on the abstinence syndrome in morphine-dependent mice. Brain Res 642:153-159.
52. Tilson HA, Rech RH and Stolman S (1973) Hyperalgesia during withdrawal as a means of measuring the degree of dependence in morphine dependent rats. Psychopharmacologia 28:287-300.
53. Trujillo KA and Akil H (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251:85-87.
54. Vaccarino F, Guidotti A and Costa E (1987) Ganglioside inhibition of glutamate-mediated protein kinase C translocation in primary cultures of cerebellar neurons. Proc Natl Acad Sci USA 84:8707-8711.
55. Woolf CJ and Thompson SW (1991) The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 44:293-299.
56. Yaksh TL and Rudy TA (1976) Chronic catheterization of the subarachnoid space. Physiol Behav 7:1032-1036.
57. Yaksh TL and Stevens CW (1986) Simple catheter preparation for permitting bolus intrathecal administration during chronic intrathecal infusion. Pharmacol Biochem Behav 25:483-485.
58. Yamamoto T and Yaksh TL (1992) Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists. Pain 49:121-128.
59. Yano I and Takemori AE (1977) Inhibition by naloxone of tolerance and dependence in mice treated acutely and chronically with morphine. Res Commun Chem Pathol Pharmacol 16:721-732.
60. Yukhananov RYU and Larson AA (1994) Involvement of NMDA receptors in naloxone-induced contractions of the isolated guinea pig ileum after preincubation with morphine. J Pharmacol Exp Ther 271:1365-1370.
61. Zhao ZQ and Duggan AW (1987) Clonidine and the hyper-responsiveness of dorsal horn neurons following morphine withdrawal in the spinal cat. Neuropharmacology 26:1499-1502.